Balance Sheet - NovaBridge Biosciences (NBP)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | |
|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 30.14 | 1,265.60 | 311.73 | 3,449.43 | 670.96 | 4,790.31 | 1,169.47 | 1,844.24 | 574.18 |
| Accounts receivable, net | 0.26 | 8.55 | 1.83 | 4.81 | 60.95 | 71.31 | 55.27 | 9.36 | 4.15 |
| Inventories | 28.96 | -80.28 | 4.27 | -55.87 | -215.57 | ||||
| Other current assets | 0.70 | 15.50 | 16.35 | 252.51 | 13.99 | 482.04 | 192.44 | 183.26 | 113.27 |
| Total current assets | 31.10 | 1,289.65 | 329.91 | 3,626.48 | 750.18 | 5,343.66 | 1,361.32 | 2,036.86 | 691.59 |
| Total non-current assets | 6.15 | 262.66 | 39.01 | 447.19 | 128.56 | 990.13 | 376.25 | 339.08 | 333.75 |
| Total assets | 37.24 | 1,552.31 | 368.92 | 4,073.67 | 878.74 | 6,333.79 | 1,737.57 | 2,375.94 | 1,025.35 |
| Total current liabilities | 3.84 | 61.70 | 58.14 | 659.74 | 97.90 | 576.13 | 588.48 | 346.16 | 195.14 |
| Total non-current liabilities | 0.38 | 22.38 | 68.19 | 405.60 | 65.52 | 130.52 | 3,183.79 | 2,984.88 | 1,130.00 |
| Total liabilities | 4.23 | 84.08 | 126.34 | 1,065.34 | 163.42 | 706.65 | 3,772.27 | 3,331.04 | 1,325.14 |
| Total stockholders' equity | 33.02 | 1,468.23 | 242.58 | 3,008.33 | 715.33 | 5,627.15 | 1,069.48 | -955.10 | 410.49 |
| Common shares outstanding | 42 | 81 | 83 | 83 | 76 | 68 | 58 | 58 | 58 |
Show Quarterly Balance Sheet
Balance Sheet - NovaBridge Biosciences (NBP)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Sep-23 | Jun-23 | Mar-23 | Sep-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Jun-20 | Mar-20 | Sep-19 | Jun-19 | Mar-19 | Dec-18 | Sep-18 | Jun-18 | Mar-18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 30.14 | 210.84 | 11,571.08 | 1,187.65 | 1,227.79 | 173.40 | 184.39 | 207.49 | 2,284.67 | 2,289.53 | 406.06 | 2,945.51 | 3,454.00 | 3,922.09 | 4,276.80 | 4,276.80 | 4,764.31 | 4,764.31 | 2,988.54 | 220.27 | 1,561.96 | 1,277.48 | 1,349.47 | 1,269.05 | 1,844.24 | 0.00 | 0.00 | 574.18 |
| Accounts receivable, net | 0.26 | 6.59 | 14.53 | 33.57 | 1.83 | 14.11 | 4.81 | 291.59 | 291.59 | 60.95 | 286.86 | 242.91 | 242.91 | 16.23 | 18.49 | 55.27 | 74.41 | 37.68 | 91.42 | 9.36 | ||||||||
| Inventories | 28.96 | 28.96 | -16.59 | 27.24 | 27.24 | 94.94 | -215.57 | |||||||||||||||||||||
| Other current assets | 0.70 | 221.56 | 15.50 | 3.82 | 22.99 | -2,250.83 | 47.14 | 3.72 | 129.34 | 172.47 | 101.00 | 416.73 | 190.82 | 4,235.90 | 208.52 | 203.61 | 0.00 | 131.13 | 76.58 | 1,370.80 | 243.95 | 183.26 | ||||||
| Total current assets | 31.10 | 217.52 | 11,799.23 | 1,202.18 | 1,261.36 | 176.69 | 188.21 | 230.48 | 2,336.67 | 2,336.67 | 423.89 | 3,074.85 | 3,626.48 | 4,314.68 | 4,781.72 | 4,781.72 | 5,215.73 | 5,215.73 | 3,208.38 | 238.76 | 1,693.09 | 1,483.37 | 1,604.42 | 1,604.42 | 2,036.86 | 574.18 | ||
| Total non-current assets | 6.15 | 43.00 | 2,262.52 | 280.16 | 260.00 | 35.99 | 44.47 | 23.35 | 276.30 | 276.30 | 60.22 | 436.85 | 447.19 | 676.89 | 847.71 | 819.48 | 932.29 | 932.29 | 1,089.69 | 50.15 | 355.64 | 356.27 | 350.92 | 350.92 | 339.08 | -574.18 | ||
| Total assets | 37.24 | 260.52 | 14,061.75 | 1,482.34 | 1,521.36 | 212.68 | 232.68 | 253.83 | 2,612.97 | 2,612.97 | 484.12 | 3,511.70 | 4,073.67 | 4,991.57 | 5,629.43 | 5,601.20 | 6,148.01 | 6,148.01 | 4,298.07 | 288.91 | 2,048.72 | 1,839.64 | 1,955.34 | 1,955.34 | 2,375.94 | |||
| Total current liabilities | 3.84 | 26.89 | 815.69 | 52.69 | 56.44 | 8.45 | 11.77 | 13.97 | 411.81 | 411.81 | 91.41 | 663.07 | 758.17 | 590.00 | 624.00 | 624.00 | 550.62 | 550.62 | 349.40 | 35.43 | 251.27 | 470.29 | 413.44 | 413.44 | 346.16 | |||
| Total non-current liabilities | 0.38 | 2.69 | 121.82 | 18.85 | 20.74 | 3.07 | 3.03 | 3.22 | -1,751.58 | 483.00 | 55.40 | 401.84 | 405.60 | 385.50 | 417.63 | 417.63 | 137.70 | 137.70 | 207.04 | 13.20 | 93.58 | 79.33 | 77.59 | 77.59 | 2,984.88 | -716.19 | ||
| Total liabilities | 4.23 | 29.58 | 937.50 | 71.53 | 77.18 | 11.52 | 14.80 | 17.19 | -1,751.58 | 894.81 | 146.81 | 1,064.91 | 1,163.76 | 975.50 | 1,041.64 | 1,041.64 | 688.32 | 688.32 | 556.44 | 48.63 | 344.85 | 549.62 | 3,406.40 | 491.04 | 3,331.04 | -716.19 | ||
| Total stockholders' equity | 33.02 | 230.94 | 13,124.25 | 1,410.81 | 1,444.18 | 201.16 | 217.88 | 236.63 | 1,751.58 | 1,718.16 | 337.31 | 2,446.78 | 2,909.90 | 4,016.08 | 4,587.80 | 4,559.56 | 5,459.70 | 5,459.70 | 3,741.64 | 240.28 | 1,703.88 | 1,290.01 | 1,464.30 | 1,464.30 | -955.10 | 716.19 | ||
| Common shares outstanding | 50 | 265 | 44 | 82 | 82 | 187 | 81 | 81 | 81 | 83 | 83 | 83 | 83 | 82 | 79 | 79 | 73 | 73 | 59 | 53 | 53 | 58 | 58 | 58 | 58 | 58 | 58 | 58 |